Coronavirus uses as binding site in humans angiotensin-converting enzyme 2 functional receptor that is involved in arterial blood pressure control and fibrotic response to damage and is a drug target in cardiovascular disease. Is this just a phylogenetic coincidence?

Ciulla, Michele M

Ciulla, Michele M.

Ciulla MM; Laboratory of Clinical Informatics and Cardiovascular Imaging, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

J Med Virol ; 92(10): 1713-1714, 2020 10.

Article in English | MEDLINE | ID: covidwho-206012

Subject(s)

COVID-19; Cardiovascular Diseases; Coronavirus; Hypertension; Pharmaceutical Preparations; Angiotensin-Converting Enzyme 2; Arterial Pressure; Binding Sites; Humans; Pandemics; Peptidyl-Dipeptidase A/genetics; Peptidyl-Dipeptidase A/metabolism; Phylogeny; SARS-CoV-2; Spike Glycoprotein, Coronavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pharmaceutical Preparations / Cardiovascular Diseases / Coronavirus / COVID-19 / Hypertension Type of study: Randomized controlled trials Limits: Humans Language: English Journal: J Med Virol Year: 2020 Document Type: Article Affiliation country: Jmv.25774

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google